PDCD1 and melanoma: Therefore, we next explored whether the addition of anti‐PD‐1 antibody (α‐PD1), a well‐known T‐cell immune checkpoint blocker, could synergistically enhance the tumor‐suppressing effects of C5‐PE38 in mice with locally primary and metastatic melanomas.